These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 20481648)

  • 21. Metabolic consequences of ileal interruption of the enterohepatic circulation of bile acids.
    van de Peppel IP; Verkade HJ; Jonker JW
    Am J Physiol Gastrointest Liver Physiol; 2020 Nov; 319(5):G619-G625. PubMed ID: 32938201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal targeting of drugs: rational design approaches and challenges.
    Filipski KJ; Varma MV; El-Kattan AF; Ambler CM; Ruggeri RB; Goosen TC; Cameron KO
    Curr Top Med Chem; 2013; 13(7):776-802. PubMed ID: 23578023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of bile formation, hepatic uptake, and biliary excretion.
    Klaassen CD; Watkins JB
    Pharmacol Rev; 1984 Mar; 36(1):1-67. PubMed ID: 6144113
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of nanotechnology in pharmaceutical product development.
    Devalapally H; Chakilam A; Amiji MM
    J Pharm Sci; 2007 Oct; 96(10):2547-65. PubMed ID: 17688284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vitro Model Simulating Gastro-Intestinal Digestion in the Pediatric Population (Neonates and Young Infants).
    Kamstrup D; Berthelsen R; Sassene PJ; Selen A; Müllertz A
    AAPS PharmSciTech; 2017 Feb; 18(2):317-329. PubMed ID: 27796909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug recirculation model with multiple cycles occurring at unequal time intervals.
    Plusquellec Y; Houin G
    J Biomed Eng; 1992 Nov; 14(6):521-6. PubMed ID: 1434577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Danazol oral absorption modelling in the fasted dog: An example of mechanistic understanding of formulation effects on drug pharmacokinetics.
    Pade D; Jamei M; Turner DB; Mistry B; Martinez MN
    Eur J Pharm Biopharm; 2019 Aug; 141():191-209. PubMed ID: 31150808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of drugs subject to enterohepatic circulation.
    Chen HS; Gross JF
    J Pharm Sci; 1979 Jun; 68(6):792-4. PubMed ID: 458586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.
    Custodio JM; Wu CY; Benet LZ
    Adv Drug Deliv Rev; 2008 Mar; 60(6):717-33. PubMed ID: 18199522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perspective on improving passive human intestinal absorption.
    Yalkowsky SH
    J Pharm Sci; 2012 Sep; 101(9):3047-50. PubMed ID: 22374839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiologically Based In vitro Models to Predict the Oral Dissolution and Absorption of a Solid Drug Delivery System.
    Li Z; He X
    Curr Drug Metab; 2015; 16(9):777-806. PubMed ID: 26264200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of cholesterol gallstones.
    LaMorte WW; Matolo NM; Birkett DH; Williams LF
    Surg Clin North Am; 1981 Aug; 61(4):765-74. PubMed ID: 7025291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters.
    Bittner B; Mountfield RJ
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):59-71. PubMed ID: 11865674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo.
    Lennernäs H; Aarons L; Augustijns P; Beato S; Bolger M; Box K; Brewster M; Butler J; Dressman J; Holm R; Julia Frank K; Kendall R; Langguth P; Sydor J; Lindahl A; McAllister M; Muenster U; Müllertz A; Ojala K; Pepin X; Reppas C; Rostami-Hodjegan A; Verwei M; Weitschies W; Wilson C; Karlsson C; Abrahamsson B
    Eur J Pharm Sci; 2014 Jun; 57():292-9. PubMed ID: 24189462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
    Alskär LC; Parrow A; Keemink J; Johansson P; Abrahamsson B; Bergström CAS
    J Control Release; 2019 Jun; 304():90-100. PubMed ID: 31047962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excipient pharmacokinetics and profiling.
    Loftsson T
    Int J Pharm; 2015 Mar; 480(1-2):48-54. PubMed ID: 25596414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transporters and xenobiotic disposition.
    Kim RB
    Toxicology; 2002 Dec; 181-182():291-7. PubMed ID: 12505328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limitations in the clinical usefulness of single-dose pharmacokinetic studies of drugs and a bayesian approach for the estimation of kinetic parameters.
    Prandota J
    Am J Ther; 2004; 11(4):295-301. PubMed ID: 15266222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excipients with specialized functions for effective drug delivery.
    Hamman J; Steenekamp J
    Expert Opin Drug Deliv; 2012 Feb; 9(2):219-30. PubMed ID: 22196483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiome-mediated bile acid modification: Role in intestinal drug absorption and metabolism.
    Enright EF; Griffin BT; Gahan CGM; Joyce SA
    Pharmacol Res; 2018 Jul; 133():170-186. PubMed ID: 29660405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.